LPS removal from an E. coli fermentation broth using aqueous two-phase micellar system

Biotechnology Progress

Volumn 26, Issue 6, 2010, Pages 1644-1653

  Lopes, André M ^a   Magalhães, Pérola O ^b   Mazzola, Priscila G ^c   Rangel Yagui, Carlota O ^a   De Carvalho, João C M ^a   Penna, Thereza C V ^a   Pessoa, Adalberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Endotoxins; Green fluorescent protein; LPS removal; Protein purification; Triton X 114

Indexed keywords

ENDOTOXINS; GREEN FLUORESCENT PROTEIN; LPS REMOVAL; PROTEIN PURIFICATION; TRITON X 114;

BIOTECHNOLOGY; ESCHERICHIA COLI; FLUORESCENCE; MICELLES; PURIFICATION;

PROTEINS;

GREEN FLUORESCENT PROTEIN; LIPOPOLYSACCHARIDE; WATER;

ARTICLE; BIOTECHNOLOGY; CHEMISTRY; CYTOLOGY; ESCHERICHIA COLI; FERMENTATION; FRACTIONATION; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICELLE;

BIOTECHNOLOGY; CHEMICAL FRACTIONATION; ESCHERICHIA COLI; FERMENTATION; GREEN FLUORESCENT PROTEINS; LIPOPOLYSACCHARIDES; MICELLES; WATER;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 78650187553     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.463     Document Type: Article

References (83)

1. Rodrigues EMG, Milagres AMF, Pessoa A Jr. Xylanase recovery: effect of extraction conditions on the AOT reversed micellar systems using experimental design. P Biochem. 1999; 3: 121-125.
2. Rodrigues EMG, Pessoa A Jr, Milagres AMF. Screening of variables in xylanase recovery using BDBAC reversed micelles. Appl Biochem Biotechnol. 1999; 77: 779-788.
3. Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991; 12: 2652-2660.
4. Hirayama C, Sakata M. Chromatographic removal of endotoxin from protein solutions by polymer particles. J Chrom B. 2002; 781: 419-432.
5. Ogikubo Y, Norimatsu M, Noda K, Takahashi J, Inotsume M, Tsuchiya M, Tamura Y. Evaluation of the bacterial endotoxin test for quantification of endotoxin contamination of porcine vaccines. Biologicals. 2004; 32: 88-93.
6. Petsch D, Anspach FB. Endotoxin removal from protein solutions. J Biotechnol. 2000; 76: 97-119.
7. Vaara M, Nurminen M. Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis. Antimicrob Agents Chemother. 1999; 43: 1459-1462.
8. Anspach FB. Endotoxin removal by affinity sorbents. J Biochem Biophys Methods. 2001; 49: 661-681.
9. Fiske JM, Ross A, VanDerMeid RK, McMichael JC, Arumugham R. Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations. J Chrom B. 2001; 753: 269-278.
10. Reichelt P, Schwarz C, Donzeau M. Single step protocol to purify recombinant proteins with low endotoxin contents. Protein Expr Purif. 2006; 46: 483-488.
11. Sharma SK. Endotoxin detection and elimination in biotechnology. Biotechnol Appl Biochem. 1986; 1: 5-22.
12. Fletcher JR, Ramwell PW. The effects of prostacyclin (PG12) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Circ Shock. 1980; 7: 299-308.
13. Fraker DL, Stovroff MC, Merino MJ, Norton JA. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med. 1988; 168: 95-105.
14. Kim Y.C. et al. Effect of pLysS on the production of bioadhesive precursor protein by fed-batch cultivation of recombinant Escherichia coli. Biotechnol Lett. 1998; 20: 799-803.
15. Lee JH. High level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem Biophys Res Comm. 2000; 277: 575-580.
16. Pyo SH, Lee JH, Park HB, Hong SS, Kim JH. A large-scale purification of recombinant histone H1.5 from Escherichia coli. Protein Expr Purif. 2001; 23: 38-44.
17. Kang Y, Luo RG. Chromatographic removal of endotoxin from hemoglobin preparations Effects of solution conditions on endotoxin removal efficiency and protein recovery. J Chrom A. 1998; 809: 13-20.
18. Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui CO, Penna TCV, Pessoa A Jr. Methods of endotoxin removal from biological preparations: a review. J Pharm Pharmaceut Sci. 2007; 10: 271-287.
19. Weary M, Pearson F. A manufacturer's guide to depyrogenation. Bio Pharm. 1988; 1: 22-29.
20. Nagaki M, Hughis RD, Kean HN, Lau JYN, Williams R. In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines. Circ Shock. 1992; 38: 182-188.
21. Shibatani T, Kakimoto T, Chibata I. Purification of high molecular weight urokinase from human urine and comparative study of two active forms of urokinase. Thromb Haemost. 1983; 28: 91-95.
22. Schindler R, Dinarello, CA. A method for removing interleukin-1 and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysulfone. J Immunol Methods. 1989; 116: 159-165.
23. Fischbach M, Heinrich E, Desprez P, Duringer R. On-line dialysate filtration: a method of dialysate endotoxin removal or only reduction? Nephron. 1994; 66: 117-118.
24. Anspach FB, Hilbeck O. Removal of endotoxins by affinity sorbents. J Chrom A. 1995; 711: 81-92.
25. Minobe S, Watanabe T, Sato T, Tosa T, Chibata I. Preparation of adsorbents for pyrogen adsorption. J Chromatogr A. 1982; 248: 401-408.
26. Minobe S, Sato T, Tosa T, Chibata I. Characteristics of immobilized histamine for pyrogen adsorption. J Chromatogr. 1983; 262: 193-198.
27. Issekutz AC. Removal of Gram-negative endotoxin from solutions by affinity chromatography. J Immunol Methods. 1983; 61: 275-281.
28. Hirayama C, Makata M, Morimoto S, Tachibe H, Ihara H, Ohkuma L, Miyachi Y. The removal of endotoxins from protein solutions using column packings with aminated poly (γ-methyl L-glutamate) spheres. Chromatographia. 1995; 40: 33-38.
29. McNeff C, Zhao Q, Almlof E, Flickinger M, Peter WC. The efficient removal of endotoxins from insulin using quaternized polyethyleneimine-coated porous Zirconia. Anal Biochem. 1999; 274: 181-187.
30. Aida Y, Pabst MJ. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods. 1990; 14: 191-195.
31. Cotten M, Baker A, Saltik M, Wagner E, Buschle M. Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. Gene Ther. 1994; 1: 239-246.
32. Adam O, Vercellone A, Paul F, Monsan PF, Puzo G. A non-degradative route for the removal of endotoxin from exopolysaccharides. Anal Biochem. 1995; 225: 321-327.
33. Jensen LB, Torp AM, Andersen SB, Skov PS, Poulsen LK, Knol EF, van Hoffen E. The biological activity of a recombinantly expressed (His)6-tagged peanut allergen (rAra h 1) is unaffected by endotoxin removal. J Immunol Methods. 2008; 335: 116-120.
34. Liu S, Tobias R, McClure S, Styba G, Shi Q, Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin Biochem. 1997; 30: 455-463.
35. Mercaldi MP, Dams-Kozlowska H, Panilaitis B, Joyce AP, Kaplan DL. Discovery of the dual polysaccharide composition of emulsan and the isolation of the emulsion stabilizing component. Biomacromolecules. 2008; 9: 1988-1996.
36. Rozkov A, Larsson B, Gillström S, Björnestedt R, Schmidt SR. Large-scale production of endotoxin-free plasmids for transient expression in mammalian cell culture. Biotechnol Bioeng. 2008; 99: 557-566.
37. (3-72)K11R/G31P expressed in Escherichia coli. Prot Exp Purif. 2008; 61: 65-72.
38. Schädlich L, Senger T, Kirschning CJ, Müller M, Gissmann L. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity. Vaccine. 2009; 27: 1511-1522.
39. Lin MF, Williams C, Murray MV, Ropp PA. Removal of lipopolysaccharides from protein-lipopolysaccharide complex by nonflammable solvents. J Chromatogr B. 2005; 816: 167-174.
40. Albertsson PÅ. Chromatography and partition of cells and cell fragments. Nature. 1956; 177: 771-774.
41. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem. 1981; 256: 1604-1607.
42. Johansson HO, Lundh G, Karlstrom G, Tjerneld F. Effect of ions on partitioning of serum albumin and lysozyme in aqueous two-phase systems containing ethylene oxide/propylene oxide copolymers. Biochim Biophys Acta. 1996; 1290: 289-298.
43. Johansson HO, Persson J, Tjerneld F. Thermoseparating water/polymer system: a novel one-polymer aqueous two-phase system for protein purification. Biotechnol Bioeng. 1999; 66: 247-257.
44. Kamei DT, King JA, Wang DIC, Blankschtein D. Separating lysozyme from bacteriophage P22 in two-phase aqueous micellar systems. Biotechnol Bioeng. 2002; 80: 233-236.
45. Kamei DT, King JA, Wang DIC, Blankschtein D. Understanding viral partitioning in two-phase aqueous nonionic micellar systems. 2. Effect of entrained micelle-poor domains. Biotechnol Bioeng. 2002; 78: 203-216.
46. Nikas YJ, Liu CL, Srivastava T, Abbott NL, Blankschtein D. Protein partitioning in two-phase aqueous nonionic micellar solutions. Macromolecules. 1992; 25: 4794-4806.
47. Sivars U, Tjerneld F. Mechanisms of phase behavior and protein partitioning in detergent/polymer aqueous two-phase systems for purification of integral membrane proteins. Biochim Biophy Acta. 2000; 1474: 133-146.
48. 3 ubiquinol oxidase, in a detergent-polymer aqueous two-phase system containing metal-chelating polymer. J Chromatogr B. 2000; 743: 307-316.
49. Rangel-Yagui CO, Lam H, Kamei DT, Wang DIC, Pessoa-Jr A, Blankschtein D. Glucose-6-phosphate dehydrogenase partitioning in two-phase aqueous mixed (nonionic/cationic) micellar systems. Biotechnol Bioeng. 2003; 82: 445-456.
50. Mazzola PG, Lam H, Kavoosi M, Haynes CA, Pessoa-Jr A, Penna TCV, Wang DIC, Blankschtein D. Affinity-tagged green fluorescent protein (GFP) extraction from a clarified E. coli cell lysate using a two-phase aqueous micellar system. Biotechnol Bioeng. 2006; 93: 998-1004.
51. Mazzola PG, Lopes AM, Hasmann FA, Jozala AF, Penna TCV, Magalhães PO, Rangel-Yagui CO, Pessoa-Jr A. Liquid-liquid extraction of biomolecules: an overview and update of the main techniques. J Chem Technol Biotechnol. 2008; 83: 143-157.
52. Jozala AF, Lopes AM, Mazzola PG, Magalhães POE, Penna TCV, Pessoa A Jr. Liquid-liquid extraction of commercial and biosynthesized nisin by aqueous two-phase micellar systems. Enzyme Microb Technol. 2008; 42: 107-112.
53. Lopes AM, Rangel-Yagui CO, Pessoa A Jr. Can affinity interactions Influence the partitioning of glucose-6-phosphate dehydrogenase in two-phase aqueous micellar systems? Quím Nova. 2008; 31: 998-1003.
54. Liu CL, Nikas YJ, Blankschtein D. Novel bioseparations using two-phase aqueous micellar systems. Biotechnol Bioeng. 1996; 52: 185-192.
55. Cunha T, Aires-Barros R. Large-scale extraction of proteins. Mol Biotech. 2002; 20: 29-40.
56. Ishii M, Kunimura JS, Penna TCV, Cholewa O. Study on the thermal stability of green fluorescent protein (GFP) in glucose parenteral formulations. Int J Pharm. 2007; 337: 109-117.
57. Barros-Neto B, Scarminio IS, Bruns RE. Como Fazer Experimentos, 3rd ed. Campinas, Brazil: Unicamp; 2007.
58. Rodrigues MI, Iemma AF. Noções sobre experimentos fatoriais and Estratégia experimental para fatoriais fracionados e delineamento composto central rotacional (DCCR). In Planejamento de Experimentos e Otimização de Processos: Uma Estratégia Sequencial de Planejamentos, 1st ed. Casa do Pão Editora, 2005: 95-153.
59. Chiarini E, Penna TCV. Extração, purificação e caracterização físico-química da proteína verde fluorescente recombinante (GFPuv) expressa em Escherichia coli. Revista Brasileira de Ciências Farmacêuticas. 2003; 39: 457-466.
60. Westphal O, Jann K. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem. 1965; 5: 83-91.
61. Hoover GJ, el Mowafi A, Simko E, Kocal TE, Ferguson HW, Hayes MA. Plasma proteins of rainbow trout (Oncorhynchus mykiss) isolated by binding to lipopolysaccharide from Aeromonas salmonicida. Comp Biochem Physiol B Biochem Mol Biol. 1998; 120: 559-569.
62. United States Pharmacopeia 24 and National Formulary 19. Bacterial Endotoxins Test. Supplement. 2000; 85: 2875-2879.
63. Albertsson PÅ. Partition of Cell Particles and Macromolecules, 3rd ed. New York: Wiley-Interscience; 1986.
64. Blankschtein D, Thurston GM, Benedek GB. Phenomenological theory of equilibrium thermodynamic properties and phase separation of micellar solutions. J Chem Phys. 1986; 85: 7268-7288.
65. Elin R, Wolff S. Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides ans proteins. J Infect Dis. 1973; 128: 349-352.
66. Morita T, Tanaka S, Nakamura T, Iwanaga S. A new (1-3)-β-D-glucana-mediated coagulation pathway found in Limulus amebocytes. FEBS lett. 1981; 129: 318-321.
67. Pearson FC, Bohon J, Lee W, Bruszer G, Sagona M, Jakubowski G, Dawe R, Morrison D, Dinarello C. Characterization of Limulus Amebocyte Lysate-reactive material from hollow-fiber dialyzers. Appl Environ Microbiol. 1984; 48: 1189-1196.
68. Fernandez A, Salager JL, Scorzza C. IV Surfactantes Noniónicos. In Modulo de Enseñanza en Fenomenos Interfaciales. Laboratorio FIRP, Escuela de Ingenieria Quimica, Universidad de Los Andes, Merida 5101 Venezuela; 2004: 15-17.
69. Food and Drug Administration. Guideline on the Validation of the Limulus Amebocyte Lysate Test As an End-product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products, and Medical Devices U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration; 1987.
70. Box GEP, Holohan R, Scott E. Statistics for Experimenters; An Introduction to Design, Data Analysis, and Model Building. Wiley; 1978; 653.
71. McNeff C, Zhao Q, Almlof E, Flickinger M, Peter WC. The efficient removal of endotoxins from insulin using quaternized polyethyleneimine-coated porous Zirconia. Anal Biochem. 1999; 274: 181-187.
72. Rietschel ET, editor. Handbook of Endotoxin. Chemistry of Endotoxin. Amsterdam: Elsevier Science; 1984.
73. Verkhusha VV, Lukyanov KA. The molecular properties and applications of Anthozoa fluorescent proteins and chromoproteins. Nat Biotechnol. 2004; 22: 289-296.
74. Zhang S, Ma C, Chalfie M. Combinatorial marking of cells and organelles with reconstituted fluorescent proteins. Cell. 2004; 119: 137-144.
75. Chalfie M, Kain S. GFP: Green Fluorescent Protein Properties, Applications, and Protocols. New York: Wiley-Liss Inc.; 2005.
76. Chudakov D, Lukyanov S, Lukyanov K. Fluorescent proteins as a toolkit for in vivo imaging. Trends Biotechnol. 2005; 23: 605-613.
77. Covassin L, Amigo JD, Suzuki K, Teplyuk V, Straubhaar J, Lawson ND. Global analysis of hematopoietic and vascular endothelial gene expression by tissue specific microarray profiling in zebrafish. Dev Biol. 2006; 299: 551-562.
78. Wachter RM. The family of GFP-like proteins: structure, function, photophysics and biosensor applications. Introduction and perspective. Photochem Photobiol. 2006; 82: 339-344.
79. Matto M, Nuutinen UM, Hakkarainen T, Tallone T, Wahlfors J, Pelkonen J. HCAR-EGFP fusion receptor in human follicular lymphoma B cells-a model for adenoviral gene therapy for B cell malignancies. Int J Mol Med. 2006; 17: 1057-1062.
80. Leeansyah E, Wines BD, Crowe SM, Jaworowski A. The mechanism underlying defective Fc gamma receptor-mediated phagocytosis by HIV-1-infected human monocyte-derived macrophages. J Immunol. 2007; 178: 1096-1104.
81. Samarkina ON, Popova AG, Gvozdik EY, Chkalina AV, Zvyagin IV, Rylova YV, Rudenko NV, Lusta KA, Kelmanson IV, Gorokhovatsky AY, Vinokurov LM. Universal and rapid method for purification of GFP-like proteins by the ethanol extraction. Prot Exp Purif. 2009; 65: 108-113.
82. Lue L, Blankschtein D. A liquid-state theory approach to modeling solute partitioning in phase-separated solutions. Ind Eng Chem Res. 1996; 35: 3032-3043.
83. United States Pharmacopoeia. National Formulary, USP30-NF25; 2007.